# Valley-Polarized Metals and Quantum Anomalous Hall Effect in Silicene

Article · Motohiko Ezawa

- Archive id: arxiv:1203.0705
- Published: 2012-08-01
- Venue: Physical Review Letters
- DOI: https://doi.org/10.1103/physrevlett.109.055502
- arXiv: https://arxiv.org/abs/1203.0705
- PMID: 23006186
- Citations: 1,045
- Source URL: https://doi.org/10.1103/physrevlett.109.055502
- PDF: https://arxiv.org/pdf/1203.0705
- Provenance: openalex+arxiv

## Abstract

Silicene is a monolayer of silicon atoms forming a two-dimensional honeycomb lattice, which shares almost every remarkable property with graphene. The low energy structure of silicene is described by Dirac electrons with relatively large spin-orbit interactions due to its buckled structure. The key observation is that the band structure is controllable by applying the electric field to a silicene sheet. We explore the phase diagram of silicene together with exchange field $M$ and by applying electric field $E\_{z}$. There appear quantum anomalous Hall (QAH) insulator, valley polarized metal (VPM), marginal valley polarized metal (M-VPM), quantum spin Hall (QSH) insulator and band insulator (BI). They are characterized by the Chern numbers and/or by the edge modes of a nanoribbon. It is intriguing that electrons have been moved from a conduction band at the K point to a valence band at the K' point for $E\_{z}\>0$ in the VPM. We find in the QAH phase that flat gapless edge modes emerge and that spins form a momentum-space skyrmion to yield the Chern number. It is remarkable that a topological quantum phase transition can be induced simply by changing electric field in a single silicene sheet.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Topological Phases & Anyons](https://space-kitty.com/topics/topological-matter)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.